Uplifting Athletes is pleased to announce global biotechnology leader CSL Behring will return as the title sponsor in 2019 for the second annual Young Investigator Draft on March 9th at Lincoln Financial Field in Philadelphia.
The Young Investigator Draft, tying the theme of the NFL Draft and Rare Disease Research together, is the result of Uplifting Athletes’ ongoing commitment to cultivate resources that accelerate scientific advancements for rare disease treatments and potential cures while facilitating the next generation of rare disease researchers.
CSL Behring is the fifth largest biotechnology company in the world. Their scientists use the latest technologies to develop and deliver innovative therapies that are used to treat rare and serious conditions, including immunodeficiency and autoimmune diseases, hereditary and acquired bleeding disorders, chronic inflammatory demyelinating polyneuropathy, hereditary angioedema and Alpha-1 antitrypsin deficiency.’
“After the phenomenal success of last year’s inaugural Young Investigator Draft, we are proud to once again have CSL Behring’s strong support,“ Uplifting Athletes Executive Director Rob Long said. “CSL Behring’s focus on rare diseases is a perfect fit for this special opportunity to bring the Rare Disease Community together to celebrate the research being conducted by these brilliant young minds.”
At the event, individual grants will be given to five Young Investigators who pursue rare disease research in these different areas: rare cancers, rare autoimmune and immunological disorders, rare blood disorders, rare genetic disorders and rare muscular and neurological disorders.
“Uplifting Athletes has added to college football’s rich history of unique traditions by applying the passion of sport to the rare disease community and creating the Young Investigator Draft,” said Jens Oltrogge, Head of Global Commercial Development, Hematology for CSL Behring. “By returning as the presenting sponsor for this unique and innovative event, we are continuing to deliver on our promise to patients and science by supporting the vitally-important work of these emerging researchers.”
The Young Investigator Draft grants are intended to inspire collaborative and translational research that will benefit the entire Rare Disease Community. The Young Investigator Draft stage will provide a platform for these young scientists to educate and inspire the audience by sharing their research along with its impact on the Rare Disease Community.
Tickets are available through the Young Investigator Draft registration page. The event will include heavy hors d’oeuvres and beer and wine prior to the program for the evening.
The challenges faced by the Rare Disease Community are bigger than any one individual, team or organization can tackle alone. At Uplifting Athletes we take pride in providing opportunity for college football student-athletes and NFL players to use the platform they are afforded to shine a spotlight on rare diseases and support the cause.
Founded in 2007, Uplifting Athletes has college football student-athlete led chapters nationwide in FBS and FCS programs from seven conferences across the country.
Since its inception, Uplifting Athletes has raised more than $4.5 million in support of the Rare Disease Community with a third of that, $1.5 million, given to fund rare disease research.